These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. Waksman R; Pakala R EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674 [TBL] [Abstract][Full Text] [Related]
5. A.R.T.: concept of a bioresorbable stent without drug elution. Lafont A; Durand E EuroIntervention; 2009 Dec; 5 Suppl F():F83-7. PubMed ID: 22100683 [No Abstract] [Full Text] [Related]
6. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis. Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302 [No Abstract] [Full Text] [Related]
7. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview. Yan J; Bhat VD EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682 [No Abstract] [Full Text] [Related]
8. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109 [TBL] [Abstract][Full Text] [Related]
9. NEVO™: a new generation of sirolimus-eluting coronary stent. Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684 [No Abstract] [Full Text] [Related]
10. Oral sirolimus after bare metal stent implantation: a glimpse to the future. Mieres J Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667 [No Abstract] [Full Text] [Related]
11. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
18. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds? Bangalore S; Mauri L EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675 [TBL] [Abstract][Full Text] [Related]
19. Current state of the absorbable metallic (magnesium) stent. Waksman R EuroIntervention; 2009 Dec; 5 Suppl F():F94-7. PubMed ID: 22100686 [TBL] [Abstract][Full Text] [Related]
20. Atheroma and coronary bifurcations: before and after stenting. Yazdani SK; Nakano M; Otsuka F; Kolodgie FD; Virmani R EuroIntervention; 2010 Dec; 6 Suppl J():J24-30. PubMed ID: 21930487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]